News

Progressive Care Inc. Announces Results of Special Meeting

Read more

Miami – (NewMediaWire) – December 9, 2021 – On

December 3, 2021, Progressive Care Inc. (the “Company” or “Progressive Care”)

held a special meeting of its stockholders (the “Special Meeting”). The record

date for stockholders entitled to notice of, and to vote at, the Special

Meeting was November 3, 2021. At the close of business on that date, the

Company had 535,430,294 shares of common stock, par value $0.0001 (“Common

Stock”) outstanding and 51 shares of Series A Preferred Stock (“Preferred

Stock”) outstanding, and entitled to be voted at the Special Meeting. At the

Special Meeting, the following three proposals were submitted to the Company’s

stockholders:

1. To approve an amendment to

the Company’s Certificate of Incorporation to effect, on or before February 16,

2023, a reverse split of the Company’s issued and outstanding common stock at a

ratio of between 1-for-10 to 1-for-250 if and when and at such ratio as may be

determined by the Company’s Board of Directors (“Proposal 1”);

2. To approve an amendment to the

Company’s Certificate of Incorporation, if and only if Proposal No. 1 is both

approved and implemented, to change the number of authorized shares of the

Company’s common stock from 1 billion (1,000,000,000) to 100 million

(100,000,000) (“Proposal 2”); and

3. To approve the adjournment of

the Special Meeting, if necessary, to solicit additional proxies if there are

not sufficient votes in favor of the foregoing proposals. (“Proposal 3”).

The final voting results were as

follows:

Proposal 1

The Company’s stockholders

approved Proposal 1. 259,216,375 shares of Common Stock and 51 shares of

Preferred Stock voted in favor of approval of the resolution, 88,388,079 shares

of Common Stock and 0 shares of Preferred Stock voted against approval of the

resolution, and 5,318,354 shares of Common Stock and 0 shares of Preferred

Stock abstained from voting for the approval of the resolution.

Proposal 2

The Company’s stockholders

approved Proposal 2. 183,520,010 shares of Common Stock and 51 shares of

Preferred Stock voted in favor of approval of the resolution, 53,039,600 shares

of Common Stock and 0 shares of Preferred Stock have voted against approval of

the resolution, and 10,111,762 shares of Common Stock and 0 shares of Preferred

Stock have abstained from voting for the approval of the resolution.

Proposal 3

The Company’s stockholders

approved Proposal 3. 284,433,452 shares of Common Stock and 51 shares of

Preferred Stock have been voted in favor of approval of the resolution,

57,690,777 shares of Common Stock and 0 shares of Preferred Stock have voted

against approval of the resolution, and 10,789,181 shares of Common Stock and 0

shares of Preferred Stock have abstained from voting for the approval of the

resolution.

Mr. Alan Jay Weisberg, CEO, and

Chairman of the Board, said, “I would like to express my appreciation to our

shareholders for trusting the Company’s Board and voting to approve the

Company’s recommendations. This vote will allow the Company to continue moving

towards accomplishing its goals of becoming a fully reporting company under the

SEC’s Exchange Act rules and becoming listed on Nasdaq. I want to assure every

one of our shareholders that we plan to carry on with our mission of redefining

healthcare, improving our financial position, and driving shareholder value.”

For more information about

Progressive Care, please visit the company’s website. Connect and stay in touch

with us on social media:

Progressive Care Inc.

https://www.facebook.com/ProgressiveCareUS/

https://twitter.com/ProgressCareUS

PharmCoRx

https://www.pharmcorx.com/

https://www.facebook.com/pharmcorx/

https://twitter.com/PharmCoRx

ClearMetrX

https://www.clearmetrx.com/

https://www.facebook.com/clearmetrx/

About Progressive Care:

Progressive Care Inc. (OTCQB:

RXMD), through its subsidiaries, is a Florida health services organization and

provider of Third-Party Administration (TPA), data management, COVID-19 related

diagnostics and vaccinations, 340B contracted pharmacy services, prescription

pharmaceuticals, compounded medications, provider of tele-pharmacy services,

the sale of anti-retroviral medications, medication therapy management (MTM),

the supply of prescription medications to long-term care facilities, and health

practice risk management.

Cautionary Disclosure Regarding Forward-Looking Statements

Forward-Looking Statements contained herein that are not based upon current or

historical fact are forward-looking in nature and constitute forward-looking statements

within the meaning of Section 27A of the Securities Act of 1933 and Section 21E

of the Securities Exchange Act of 1934. Such forward-looking statements reflect

the Company’s expectations about its future operating results, performance, and

opportunities that involve substantial risks and uncertainties. When used

herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,”

“target,” “intend” and “expect” and similar expressions, as they relate to

Progressive Care Inc., its subsidiaries, or its management, are intended to

identify such forward-looking statements. These forward-looking statements are

based on information currently available to the Company and are subject to a

number of risks, uncertainties, and other factors that could cause the

Company’s actual results, performance, prospects, and opportunities to differ

materially from those expressed in, or implied by, these forward-looking

statements.

Public Relations Contact:

Carlos Rangel

carlosr@pharmcorx.com

Source link

The post Progressive Care Inc. Announces Results of Special Meeting first appeared on Smallcaps Daily.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button